Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neuroblastoma × Celecoxib × Clear all

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Sarcoma 3 Neoplasms 3 Neoplasm Metastasis 3 Thymoma 2 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Melanoma 2 Leukemia, Myelomonocytic, Chronic 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neuroblastoma 1

Interventions

Cyclophosphamide 29 Filgrastim 16 Topotecan 13 Temozolomide 12 Irinotecan 12 Melphalan 11 Granulocyte Colony-Stimulating Factor 11 fludarabine 10 Peripheral Blood Stem Cell Transplantation 10 Vincristine 9 Etoposide 9 Isotretinoin 8 Busulfan 8 dinutuximab 7 humanized 3F8 anti-GD2 monoclonal antibody 6 fludarabine phosphate 6 Interleukin-2 6 Doxorubicin 6 Carboplatin 6 3-Iodobenzylguanidine 6 sargramostim 5 aldesleukin 5 Vorinostat 5 Stem Cell Transplantation 5 Cisplatin 5 etoposide phosphate 4 Zoledronic Acid 4 ribociclib 3 Oxaliplatin 3 Ipilimumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02030964 2025-02-17

DFMO

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡